Cargando…
Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis
BACKGROUND: The objective of this study was to evaluate the efficacy of a combination of gemcitabine and docetaxel (GD) as a second-line treatment for elderly patients with metastatic urothelial carcinoma (mUC). PATIENTS AND METHODS: A total of 122 patients with mUC who were previously treated with...
Autores principales: | Naiki, Taku, Iida, Keitaro, Etani, Toshiki, Nagai, Takashi, Tanaka, Yutaro, Sugiyama, Yosuke, Ando, Ryosuke, Hamamoto, Shuzo, Banno, Rika, Nagata, Daisuke, Kawai, Noriyasu, Yasui, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152597/ https://www.ncbi.nlm.nih.gov/pubmed/30271215 http://dx.doi.org/10.2147/CMAR.S172913 |
Ejemplares similares
-
A pilot study of gemcitabine and paclitaxel as third-line chemotherapy in
metastatic urothelial carcinoma
por: Naiki, Taku, et al.
Publicado: (2017) -
Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy
por: Naiki, Taku, et al.
Publicado: (2017) -
A Case of Metastatic Urothelial Carcinoma Treated with Pemetrexed as Third-Line Chemotherapy with Discussion and Literature Review
por: Iida, Keitaro, et al.
Publicado: (2015) -
Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder
por: Nagai, Takashi, et al.
Publicado: (2016) -
Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade
por: Nagai, Takashi, et al.
Publicado: (2018)